Doral (Quazepam) Shortage Update: What Patients Need to Know in 2026

If you've been prescribed Doral (quazepam) and are struggling to find it at pharmacies, you're dealing with a situation that's real — even if it doesn't appear on any official shortage list. This article provides a comprehensive 2026 update on Doral and generic quazepam availability, explaining what's happening and what options you have.

Is Doral (Quazepam) Officially in Shortage?

As of early 2026, quazepam is not listed on the FDA's Drug Shortage Database. It is also not on the American Society of Health-System Pharmacists (ASHP) shortage list. However, this doesn't mean patients can simply walk into any pharmacy and get it filled.

The situation with Doral is what could be called a "de facto unavailability" — the medication exists in the supply chain, but distribution is so limited that most patients can't access it through normal pharmacy channels.

What Happened to the Brand Name Doral?

The original brand name Doral tablets have been discontinued by their manufacturer. According to data from GoodRx and FDA drug listings, the brand version was discontinued as of late 2025. This is a common scenario in the pharmaceutical industry — a brand drug with declining sales eventually becomes unprofitable to market, even if its generic equivalent remains available.

The generic version, quazepam 15 mg, is still being manufactured by companies including Atland Pharmaceuticals. However, its distribution is limited primarily to specialty pharmacy channels rather than retail distribution networks.

Why Can't I Find Quazepam at Regular Pharmacies?

Several factors contribute to the practical unavailability at retail pharmacy chains:

• Extremely low prescription volume. Zolpidem alone accounts for a majority of all sleep prescription fills in the U.S. Quazepam represents a tiny fraction. Pharmacies stock what they routinely dispense.
• Brand discontinuation ripple effect. When the brand is discontinued, awareness declines. Pharmacists may not know where to source the generic.
• Controlled substance logistics. As a Schedule IV drug, quazepam requires DEA compliance and special ordering procedures that make it unattractive for pharmacies to stock in small quantities.
• Limited distributor coverage. Not all major pharmaceutical wholesalers (McKesson, AmerisourceBergen, Cardinal Health) readily supply quazepam through their standard retail pharmacy networks.

The History of Doral Availability Problems

Patients have been reporting difficulty finding quazepam for years. Online pharmacy forums and patient communities document consistent accounts of patients being told by multiple pharmacies that quazepam isn't available through their distributors. This is a long-standing structural issue rather than a sudden shortage event.

The situation got worse when the branded version was discontinued. Previously, pharmacies that stocked brand Doral were at least one source of supply. Without the brand, patients and even pharmacists are often unsure where to turn.

What Is the Current Availability Situation in 2026?

In 2026, quazepam is:

• Available through Sterling Specialty Pharmacy (mail-order nationwide)
• Potentially orderable by independent pharmacies through select distributors
• Not routinely stocked at chain pharmacies (CVS, Walgreens, Rite Aid, Kroger, Walmart)
• Not on any official shortage list (FDA or ASHP)

What Can Patients Do Right Now?

The most effective strategies for patients in 2026:

1. Contact Sterling Specialty Pharmacy at 888-618-4126. They stock quazepam and can mail prescriptions to patients across the country. Your doctor can e-prescribe to e-scribe #2433693 or fax to 866-588-0371.
2. Use medfinder to search pharmacies in your area. medfinder calls pharmacies near you to check which ones can actually fill your quazepam prescription and texts you the results.
3. Ask independent pharmacies to special-order it. They have more flexibility than chain pharmacies to source uncommon medications.
4. Discuss alternatives with your doctor. See our guide on Doral alternatives for insomnia for options like temazepam, zolpidem, and eszopiclone that are widely stocked at retail pharmacies.

The Bottom Line for 2026

Doral (quazepam) is not in a formal shortage, but it's also not easily accessible through normal pharmacy channels. The brand has been discontinued, and the generic is distributed through limited specialty pharmacy networks. Patients who need it will need to use specialty pharmacy channels or work with medfinder to locate pharmacies that can fill it.